In the pipeline: Trastuzumab-DM1 active after HER2 therapy fails - Commentary

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{aa07290a5c734a33ba046b66928926e5,

title = "In the pipeline: Trastuzumab-DM1 active after HER2 therapy fails - Commentary",

author = "Gradishar, {William J.}",

year = "2009",

month = sep,

day = "1",

language = "English (US)",

journal = "Oncology Report",

issn = "1548-5323",

publisher = "Elsevier BV",

number = "FALL",

}

TY - JOUR

T1 - In the pipeline

T2 - Trastuzumab-DM1 active after HER2 therapy fails - Commentary

AU - Gradishar, William J.

PY - 2009/9/1

Y1 - 2009/9/1

UR - http://www.scopus.com/inward/record.url?scp=78650329687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650329687&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:78650329687

SN - 1548-5323

JO - Oncology Report

JF - Oncology Report

IS - FALL

ER -